PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. Store at -20°C. Avoid freeze/thaw cycles.
Lead Time
Typically, we can ship the products within 1-3 business days of receiving your order. Delivery times may vary depending on the purchasing method or location. Please consult your local distributors for specific delivery timeframes.
CD5 may act as a receptor in regulating T-cell proliferation.
Gene References Into Functions
These findings support the notion that CD5 is not only a phenotypic marker but a relevant player in CLL cell biology. Germline-defined functional CD5 variants influence CLL outcome. PMID: 26991857
ZAP70 is the only gene differentially expressed in CD5-high and CD5-low normal B-lymphocytes, confirming the crucial role of Zap-70 tyrosine kinase in BCR signaling alterations in B-CLL. PMID: 29125235
High CD5 plasma levels in patients with severe ASD suggest a potential involvement of CD5 in the physiology of autism. However, further investigation with larger populations is needed to determine whether elevated CD5 levels are a consequence of autism or play a pathogenic role. PMID: 28406773
A CD34-negative MYC-rearranged B-lymphoblastic lymphoma aberrantly expresses CD3 and CD5. PMID: 28280048
This study provides insights into the regulation of CD5 expression on leukemic T cells, potentially aiding in understanding the molecular mechanism of CD5 down-regulation. PMID: 28752543
CD5 transcription is increased, resulting in the production of three mRNA isoforms by APA, all contributing to protein production at different levels. PTBP1 binds in the vicinity of pA1, leading to an increase in mRNA levels, and miR-204 targets the longer CD5 mRNA. PMID: 27005442
High CD5 expression is associated with lymphoma in Waldeyer ring. PMID: 27616053
Trans-signaling of IL-6 can only occur via sIL-6R, but not sCD5. PMID: 28159554
The majority of CD5(low) B cells in patients are leukemic, identifying CD5(low) B cells as a significant component of CLL. This finding has implications for CLL pathogenesis, clinical monitoring, and the development of anti-CD5-directed therapies. PMID: 27693386
The CD5 Pro224-Ala471 haplotype in homozygosis improved melanoma survival in the entire set of patients. These findings highlight the relevance of genetic variability in immune-related genes for clinical outcome in melanoma. PMID: 27169428
R-EPOCH therapy does not seem to impact the known poorer prognosis of patients with de novo CD5+ diffuse large B-cell lymphoma, and CD5 expression remains an independent prognostic factor in R-EPOCH-treated patients with diffuse large B-cell lymphoma. PMID: 28039906
CD5+B lymphocytes were increased and activated in autoimmune hemolytic anemia patients. PMID: 26968550
This study confirms the poor prognosis of de novo CD5+ DLBCL in a large multi-center cohort despite initial rituximab-containing chemotherapy and suggests that stem cell transplantation fails to salvage the majority of these patients. PMID: 26800311
5.2% were positive for CD5 and 5.7% positive for epstein-Barr virus encoded RNA. PMID: 26369546
CD5 polymorphisms are associated with systemic lupus erythematosus. PMID: 25402503
Three tyrosine-based domains within the CD5 cytoplasmic tail promote T-cell survival through non-overlapping mechanisms. PMID: 26363459
A case of mantle cell lymphoma with a unique pattern of CD5 negative to positive expression switching in relapse. PMID: 24166616
CD5 expression is useful in distinguishing thymic carcinoma from poorly differentiated lung carcinoma. PMID: 23958552
The proportion of CD5+ B cells at 1 month of age is inversely correlated with total IgG levels at 18 and 36 months of age. PMID: 24928995
Down-regulation of CD5 on activated CD8(+) T cells may serve as a useful marker of dysregulated T cell activation and proliferation in FHL2. PMID: 24051121
CD5 expression in nodal marginal zone lymphoma correlates with a higher frequency of dissemination, but patients have an indolent clinical course and excellent overall survival. PMID: 24124149
Our results indicate that CD5(+) B cell subsets might be associated with the pathogenesis of SPMS. PMID: 22732449
Functional CD5-dependent casein kinase 2 signaling is necessary in a CD5 knock-in mouse for efficient differentiation of naïve CD4+ T cells into T helper (Th)2 and Th17 cells, but not Th1-type cells. PMID: 22904299
Case Report: CD5-positive marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) of the lung. PMID: 22333190
Our results show that CD5 expression is rare in MALT lymphoma and is often associated with nongastric disease and an increased tendency to present with disseminated disease. PMID: 22406370
Hepatitis C virus infection of human T lymphocytes is mediated by CD5. PMID: 22278227
The primary carcinoma showing thymus-like elements of the thyroid frequently expresses KIT and CD5 proteins. PMID: 21835435
Alternative costimulation via CD5, rather than classic costimulation via CD28, primes naïve T cells for stable Th17 development through promoting the expression of IL-23R. PMID: 21926348
Post-thymic regulation of CD5 levels in human memory T cells is inversely associated with the strength of responsiveness to interleukin-15. PMID: 21539877
Immunological significance of CD19 for the IL-10 production by CD5(+) B cells. PMID: 21786452
Case Report: Describes the recurrence of CD5 positive MALT lymphoma in the oral cavity and compares the immunohistochemical expressions of CD5, lambda, and kappa between the primary and recurrent tumors. PMID: 21892966
CD5 glycoprotein-mediated T cell inhibition dependent on inhibitory phosphorylation of Fyn kinase. PMID: 21757751
Conclude that high percentages of CD5+B cells independently associate with an increased risk of early conversion to multiple sclerosis in clinically isolated syndrome patients. PMID: 21436320
Data show that CD5 expression is associated with NFAT2 activity and mildly STAT3 activity, indicating that CD5 controls IL-10 secretion. PMID: 21398617
The full-length protein variant, encoded by E1A-cd5, translocates the phosphatase SHP-1 to the vicinity of the B-cell receptor, raises its threshold, and thereby limits the response of autoreactive B cells [review]. PMID: 21395509
CD5-positive splenic marginal zone lymphoma may be related to memory B-cell neoplasm or plasma cell differentiation. PMID: 21123968
Type B3 thymic epithelial tumor in an adolescent detected by immunohistochemical staining for CD5, CD99, and KIT (CD117): a case report. PMID: 19901887
CD5-negative regulation of B cell receptor signaling originates from tyrosine residue Y429 outside an immunoreceptor tyrosine-based inhibitory motif. PMID: 11751967
Origins and functions of B-1 cells with notes on the role of CD5. Review. PMID: 11861604
Multiple somatic mutations in human cancers. The value of the CD5 microsatellite as a marker for instability in different tumor types, particularly in B-cell leukemia and lymphoma. PMID: 11869933
CD5 supports the survival of B cells by stimulating IL-10 production and by concurrently exerting negative feedback on BCR-induced signaling events that can promote cell death. PMID: 12393419
CD5-negative, CD10-negative small B-cell leukemia: variant of chronic lymphocytic leukemia or a distinct entity. PMID: 12447961
CD5 is rapidly recruited at the immunological synapse (IS) and lowers the T cell response elicited by antigen presentation by targeting downstream signaling events without affecting IS formation. PMID: 12707340
The CD5+ diffuse large-B-cell lymphoma (DLBCL) constitutes a disease category distinct from that of CD5- DLBCL and other CD5+ malignancies. PMID: 14603444
The 5'-flanking region of human CD5 is transcriptionally active in T cells, and Ets transcription factors in conjunction with other regulatory elements are responsible for constitutive and tissue-specific CD5 expression. PMID: 15187131
Overexpression in these cells indicates disease progression in B-cell leukemia patients. PMID: 15549146
CD5 is associated with receptor revision in activated mature B cells and likely to promote expression of suitable immunoglobulin gene receptors capable of initiating the germinal center reaction. PMID: 15843554
The polymorphic CD5 promoter is associated with increased susceptibility to B-cell chronic lymphocytic leukemia and mantle cell lymphoma. PMID: 15981803
The balance between the 2 alternative exons 1 might be central to the regulation of membrane CD5 in human B cells. PMID: 15998834
Analysis of CD5-positive diffuse large B-cell lymphoma with the unusual phenotype of cytoplasmic CD20 (+), surface CD20 (-). [case report] PMID: 16923582